UK SAYS IT IS TOO EARLY TO KNOW WHETHER OMICRON VARIANT HAS ANY IMPACT ON SOTROVIMAB'S EFFECTIVENESS BUT MHRA WILL WORK WITH COMPANY TO ESTABLISH THIS
Stock Market News in real time
- Stock Market
- Stock Market News in real time
- Economy
- Uk Says It Is Too Early To Know Whether Omicron Variant Has Any Impact On Sotrovimab's Effectiveness But Mhra Will Work With Company To Establish This